Although dietary saturated fatty acids (SFA) are considered atherogenic, associations between SFAs intake and stroke and coronary heart disease are still debated. We sought to test the hypothesis that SFA intake is associated inversely with risk of stroke and its subtypes and positively with coronary heart disease among Japanese, whose average SFA intake is lower than that of Westerners.
Introduction
Saturated fatty acid (SFA) intake has been considered to be atherogenic, and it is suggested that reducing SFA intake prevents atherosclerotic diseases. 1 Yet, recent meta-analyses have indicated that greater dietary intake of SFA per se may not be associated with increased risk of coronary disease, 2, 3 though another meta-analysis showed that replacing SFA intake with polyunsaturated fatty acids (PUFA) intake was inversely associated with coronary events. 4 Several cohort studies, but not all, have reported an inverse association between dietary SFA and risk of ischaemic stroke and/or intraparenchymal haemorrhage. 3 Thus, the role of SFA intake in the development of both coronary diseases and stroke remains under debate.
Compared with Westerners, Asian people traditionally consume less SFA-containing foods, as shown in the Seven Countries Study 5 and also in later studies. 6, 7 The low SFA intake among Asians has been believed to be one reason why they have lower mortality from coronary disease than Westerners. However, no prospective studies have been conducted to examine the association between dietary SFA intake and incident stroke and coronary disease in Asians, except for intraparenchymal haemorrhage. 6 The Japan Public Health Center-based prospective (JPHC) Study is one of the largest prospective studies in Japan, with a systematic incidence registry of cardiovascular disease. An advantage of this study included enough number of population to study subtypes of stroke (i.e. subarachnoid, deep or lobar intraparenchymal haemorrhage and lacunar, large-artery occlusive or embolic infarction), which is often hard to study in Western cohorts. The population is also unique in that they have very low SFA intake and high stroke and low coronary disease incidence. Our hypotheses were that low SFA intake is associated with elevated risk of deep intraparenchymal haemorrhage and lacunar infarction, and high SFA intake with elevated risk of coronary heart disease.
Methods

Study cohort
The JPHC Study is an ongoing cohort study comprising a communitybased sample of 140 420 persons (68 722 men and 71 698 women) in Japan. Details of the JPHC Study protocol were given elsewhere. 8 Briefly, the JPHC Study included two subcohorts based on Public Health Center areas; Cohort I (started in 1990, five Public Health Center areas, participants aged 40-59) and Cohort II (started in 1993, six PHC areas, aged 40-69); however, participants in two Public Health Center areas (Tokyo and Osaka) were excluded from the current study because the follow-up data were incomplete. Thus, 116 896 subjects, all residents living in the study areas at baseline, were eligible for follow-up. Participants were asked to complete selfadministered questionnaires about their lifestyles and medical histories. Informed consent was obtained before participants completed the questionnaire, or sometimes from community leaders instead of individuals, as this had been in common practice for informed consent in Japan at that time. The JPHC study was approved by the institutional review boards of the National Cancer Center and the University of Tsukuba.
Baseline questionnaires
A self-administrated questionnaire was distributed to all residents aged 40 -59 living in the study areas for Cohort I in 1990 and those aged 40 -69 for Cohort II in 1993. The questionnaire included demographic characteristics, medical history, smoking, drinking, and dietary habits. A 5-year follow-up questionnaire, which includes food frequency questionnaire (FFQ), was distributed to all eligible study subjects in 1995 for Cohort I and in 1998 for Cohort II. Of these, 92 905 persons (79%) returned their follow-up questionnaire. We excluded persons who lost or refused follow-up (n ¼ 226); who had histories of myocardial infarction, angina pectoris, stroke, or cancer based on the first or 5-year follow-up questionnaires or who were found in the stroke/coronary heart disease registry (n ¼ 7964); or who did not satisfactorily complete their dietary questionnaire (n ¼ 1114). We further excluded persons with total energy intake ,1 or .99 percentile (n ¼ 1670). Ultimately, 81 931 (38 084 men and 43 847 women) were included in this study.
The FFQ in the 5-year follow-up of Cohorts I and II was used to determine the dietary intake of SFA and other nutrients/foods. The FFQ included 138 food items and 4 choices for frequency of intake was offered for each item. The nutrients that each food item contained were mostly estimated by the Japan Food 10 The mean intake of SFA derived from FFQ was 11 -31% higher than that from dietary records. Reproducibility of FFQ was also confirmed for Cohort II at 1-year interval and was fairly good (Spearman r ¼ 0.61 among men and 0.53 among women). 10 All dietary variables were adjusted for energy intake using the nutrient residual model.
11
Stroke and coronary heart disease registries A total of 78 hospitals formed the register of events within the nine PHC areas. All were major hospitals with the capability of treating patients with acute coronary heart disease, stroke, or cancer events. Ninety-seven per cent of strokes and 92% of myocardial infarctions in the nine PHC areas were treated at these 78 registry hospitals. Physicians in the hospitals, PHCs, or investigators, blinded to the patients' lifestyle data, reviewed the medical records of cohort participants at each hospital, and extracted clinical information including brain images, electrocardiogram, and enzymes, onto cohort-specific registration forms. Stroke was confirmed according to the criteria of the National Survey of Stroke, 12 which requires the presence of focal neurological deficits of sudden or rapid onset lasting at least 24 h or until death. Strokes were classified according to subtypes, i.e. intraparenchymal haemorrhage (deep or lobar), subarachnoid haemorrhage, or cerebral infarction (large-artery thrombotic, lacunar, or embolic). 13 Almost all the registered hospitals were equipped with CT and/or MRI scans. Imaging was available for 98% of registered stroke events. Myocardial infarction was confirmed in the medical records according to the criteria of the Monitoring Trends and Determinants of Cardiovascular Disease (MONICA) project, 14 which requires typical chest pain and evidence from electrocardiogram and/or cardiac enzymes. For cases with typical prolonged chest pain (.20 min) but not confirmed by electrocardiograms or cardiac enzymes (11% of total myocardial infarctions), a possible myocardial infarction diagnosis was made and these were included in myocardial infarction cases. Sudden cardiac death was defined as a death of unknown origin that occurred within 1 h of the onset of the event.
For analysis, only first-ever stroke (regardless of subtype) or coronary heart disease (myocardial infarction or sudden cardiac death) events during the follow-up were included; recurrent events were excluded. If one person suffered both coronary heart disease and stroke, both events were included.
Statistical analyses
Follow-up started from the completion of the 5-year questionnaire and ended at the date of death, emigration, incident stroke or coronary heart disease event, or end of 2009 (for Cohort I) or end of 2007 (for Cohort II), whichever came first. The incidence rates of each outcome were calculated according to quintiles of energy-adjusted SFA intake. Hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated after adjustment for age, sex, and other covariates with Cox proportional hazard models. The covariates included cohort; baseline body mass index (quintile); smoking status (never, ex-, current smoker of 1 to ,20, 20 to ,30, and 30 cigarettes/day or more); alcohol intake (0, 1 -150, 151 -300, 301 -450, and 451 g/ week or more); sports at leisure time (rarely, 1 -3/month, 1 -2/ week, 3 -4/week, or more); walking and standing time (,1, 1-3, 3 h/day or more); perceived mental stress (low, medium, high); employment status (non-employed or employed); total energy intake (quintile); and quintiles of energy-adjusted dietary intakes of carbohydrate, cholesterol, vegetables, fruit, and calcium. We did not include MUFA and PUFA in the model, so the results should be interpreted as the association of SFA in exchange for the average combination of types of fat other than SFA (i.e. MUFA and PUFA). We also did not include serum lipids, hypertension, or diabetes, since these could be potential mediators for the relation between SFA intake and cardiovascular outcomes. The linear trend of HRs across quintiles was tested by an ordinal variable (22, 21, 0, +1, +2) for successive quintiles. Multiplicative interactions with sex were tested using a cross-product term. The proportional hazards assumption was tested using time by SFA interaction terms and was not violated for each outcome.
We used SAS version 9.1.3 Service Pack 4 (SAS Institute, Inc., Cary, NC, USA) for the analyses. All probability values for statistical tests were two-tailed and values of P , 0.05 were regarded as statistically significant. cardiac deaths were registered. There were no statistical interactions between SFA and sex in relation to any cardiovascular outcomes. Therefore, we pooled men and women for analyses. As shown in Table 2 , SFA intake was inversely associated with age-; sex-; and energy-adjusted incidence rates of total stroke, total and deep intraparenchymal haemorrhages, ischaemic stroke, lacunar infarction, and total cardiovascular disease. On the other hand, SFA intake was positively associated with myocardial infarction, but not associated with subarachnoid haemorrhage or sudden cardiac death. Further adjustment for potential cardiovascular risk factors and nutrients did not change these results substantially. There was no interaction between sex and SFA intake in relation to each outcome. The sex-specific baseline characteristics, the number of each event, multivariable HRs, and P for trend were presented in Supplementary material online, Tables  S1-S3 .
We consider hypertension and diabetes to be on the causal pathway between SFA and cardiovascular outcomes. When we included treatment for hypertension and diabetes in the model, the results were similar for total stroke [multivariable HR for highest vs. lowest SFA quintiles 
Discussion
We observed an inverse relationship between dietary intake of SFA and stroke, consistent with some previous studies, 6,15 -18 but not all. 19 -22 The major strengths of this study were the large sample size and the availability of stroke subtypes, with 98% of cases diagnosed by CT/MRI imaging. We revealed that the inverse association of SFA intake with stroke incidence was mainly due to its association with the incidence of deep intraparenchymal haemorrhage and lacunar infarction. We also found that the association between SFA intake and myocardial infarction was positive, the first epidemiological observation in Asia, but the overall association between SFA intake and total cardiovascular disease was inverse and was driven by its inverse association with stroke. Figure 1 Comparison of the association between saturated fatty acid intake and crude incidence/mortality rates (per 100 000 person-years) of haemorrhagic stroke (A), ischaemic stroke (B), and coronary heart disease/myocardial infarction (C According to the national statistics, Japanese consumed SFA far less than Americans (mean intakes were 16-17 g among Japanese in 1988-93 vs. 33 and 22 g for American men and women, respectively, in 1989-91). 23, 24 In contrast, they have much higher incidence of intraparenchymal haemorrhage and lacunar infarction. 25 This ecological association suggested that their high incidence of both intraparenchymal haemorrhage and lacunar infarction could be attributed to low SFA intake since haemorrhage and ischaemia in the perforator area of the brain is reported to share a common pathological condition (i.e. cerebral small vessel pathology called arteriolosclerosis), 26 and the presence of arteriolosclerosis has been associated with very low blood total cholesterol levels 27 attributable in part to low SFA consumption. The present finding would be consistent with previous observations that very low blood total or LDL cholesterol levels, 28 -31 as well as low SFA intake, 6, 16 were associated with increased risk of intraparenchymal haemorrhage.
We found a positive association between SFA intake and myocardial infarction incidence, primarily for men, but not for women, although there was no sex interaction. This is compatible with the result of a previous Japanese study showing a similar sex difference in the association between LDL cholesterol and mortality from myocardial infarction. 32 Major reasons for no association among women in the present study would be a small number of incident myocardial infarction, but could also relate to the attenuated LDL cholesterol levels by sex hormones and/or the low incident rate of myocardial infarction, which might obscure the adverse coronary effect of high SFA intake. Much lower smoking rate in women may also be related. 33 The null associations in women were in line with the results of other studies such as the Nurses' Health Study. 34 The distribution of SFA intake in the present study population was significantly lower than that for USA or European populations, and the cardiovascular disease profile is also different. Therefore, we plotted SFA intake and crude incidence of or mortality from haemorrhagic stroke, ischaemic stroke, and coronary heart disease from the present and other published literature, 6, 17, 18, 21, 35, 36 where information on absolute amount of daily SFA intake was available ( Figure 1 ). Taken together with the other studies, there seems to be a threshold around 20 g/day of SFA intake for inverse relation of SFA intake with stroke, especially with haemorrhagic stroke. There could be an optimal level of SFA intake, which should be confirmed by meta-analyses.
Haemorrhage in the perforator area and lacunar infarction in Western populations are not as common as those in Asians. 37 The present results may be extrapolated to Asian populations that share dietary habits and cardiovascular disease profiles with Japan, but not necessarily to populations with Western lifestyles. Although there is no clinical trial evidence, we speculate that people consuming below optimal level, if any, of SFA might benefit by modestly increasing their SFA intake. However, even in Japanese, this could increase the risk of myocardial infarction especially in men. Therefore, recommendation to increase SFA intake cannot made in current Japan, since both SFA intake and coronary heart disease incidence rate are increasing among urban Japanese men. 38, 39 We did not include hypertension and diabetes, since we consider them mediators of the associations, as SFA was reported to affect insulin resistance and blood pressure. 40 -42 In the present study, the adjustment for treatment of hypertension and diabetes weaken the association between SFA intake and risk of ischaemic stroke, suggesting that the association was mediated largely by hypertension and diabetes. As far as we know, this is the first study to examine the association between SFA intake and stroke subtypes. In addition, this is the first study to examine the association between SFA intake and risk of myocardial infarction among Asians. Other strengths of this study include the prospective cohort design, systematic registration of stroke and coronary heart disease incidence, high availability of CT/MRI imaging for stroke diagnosis, reasonable number of events for statistical power, and multiple adjustments for relevant confounders. Limitations of this study, however, warrant discussion. First, the use of a FFQ inevitably leads to SFA misclassification, although the FFQ was validated by dietary records. Random misclassification of SFA would typically attenuate observed associations. Secondly, persons with low SFA intake in the present study were older (women), leaner (men), more hypertensive, less diabetic (men), less active, and more likely to be current smokers and drinkers (men) and to have fruit (women). Although we adjusted for a number of covariates, there would still be a potential residual confounding by other dietary and/or socioeconomic factors. Thirdly, the present study was not sufficient to prove the causality. The effects of increasing or decreasing SFA intake on the incidence of different types of cardiovascular disease should be evaluated ideally by randomized controlled trial.
In conclusion, we found an inverse association between dietary intake of SFA and risk of stroke, primarily for deep intraparenchymal haemorrhage and lacunar infarction, and a positive association between SFA intake and risk of myocardial infarction among Japanese.
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